BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25286148)

  • 1. Unicentric Castleman disease: from screening mammography to PET/CT imaging.
    Szturz P; Prášek M; Rehák Z; Fabian P
    Nuklearmedizin; 2014; 53(5):N41-3. PubMed ID: 25286148
    [No Abstract]   [Full Text] [Related]  

  • 2. Castleman disease of the porta hepatis mimicking exophytic hepatocellular carcinoma on CT, MRI, and FDG PET/CT.
    Dong A; Dong H; Zuo C
    Clin Nucl Med; 2014 Jan; 39(1):e69-72. PubMed ID: 23486333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
    Zhang X; Wu F; Han P
    Hell J Nucl Med; 2014; 17(3):177-83. PubMed ID: 25526754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary lymph node characterization in breast cancer patients using magnetic resonance mammography: a prospective comparative study with FDG PET-CT and healthy women.
    Krammer J; Wasser K; Schnitzer A; Henzler T; Schoenberg SO; Kaiser CG
    Eur J Radiol; 2013 Dec; 82(12):2194-8. PubMed ID: 23993142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal bone marrow involvement in multicentric castleman disease demonstrated by FDG PET/CT.
    Ramos CD; Massumoto CM; Rosa MF; Mazo-Ruiz MF; Mitteldorf C; Etchebehere EC; Santos AO; Lima MC; Cerri GG; Camargo EE
    Clin Nucl Med; 2007 Apr; 32(4):295-6. PubMed ID: 17413577
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/CT findings in a multicentric form of Castleman's disease.
    Halac M; Ergul N; Sager S; Demir A; Buyukpinarbasli N; Sonmezoglu K
    Hell J Nucl Med; 2007; 10(3):172-4. PubMed ID: 18084659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body MR or PET-CT?
    Schmidt GP
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S142-3. PubMed ID: 23083566
    [No Abstract]   [Full Text] [Related]  

  • 9. 18F-FDG PET/CT findings in patients with Kikuchi disease.
    Kong E; Chun K; Hong Y; Hah J; Cho I
    Nuklearmedizin; 2013; 52(3):101-6. PubMed ID: 23681151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
    Machida Y; Kubota K; Katayama T; Toriihara A; Shibuya H
    Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
    Blom RL; Vliegen RF; Schreurs WM; Belgers HJ; Stohr I; Oostenbrug LE; Sosef MN
    Dis Esophagus; 2012 Aug; 25(6):555-9. PubMed ID: 22150869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of Castleman's disease: mimics, radiologic pathologic correlation and role of imaging in patient management.
    Madan R; Chen JH; Trotman-Dickenson B; Jacobson F; Hunsaker A
    Eur J Radiol; 2012 Jan; 81(1):123-31. PubMed ID: 20643523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
    Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in breast cancer.
    Bernsdorf M; Graff J
    Clin Physiol Funct Imaging; 2014 Nov; 34(6):426-33. PubMed ID: 24267489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
    Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
    Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of breast cancer in an FDG-PET cancer screening program: results of a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Clin Breast Cancer; 2015 Apr; 15(2):e139-46. PubMed ID: 25454690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality imaging and clinical features in Castleman disease: single institute experience in 30 patients.
    Hill AJ; Tirumani SH; Rosenthal MH; Shinagare AB; Carrasco RD; Munshi NC; Ramaiya NH; Howard SA
    Br J Radiol; 2015 May; 88(1049):20140670. PubMed ID: 25710283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer.
    Peng Z; Liu Q; Li M; Han M; Yao S; Liu Q
    Clin Lung Cancer; 2012 Jul; 13(4):312-20. PubMed ID: 22182444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.